Document Detail

Recrudescent Plasmodium berghei from pregnant mice displays enhanced binding to the placenta and induces protection in multigravida.
Jump to Full Text
MedLine Citation:
PMID:  19461965     Owner:  NLM     Status:  MEDLINE    
Pregnancy-associated malaria (PAM) is associated with placenta pathology and poor pregnancy outcome but the mechanisms that control the malaria parasite expansion in pregnancy are still poorly understood and not amenable for study in human subjects. Here, we used a set of new tools to re-visit an experimental mouse model of pregnancy-induced malaria recrudescence, BALB/c with chronic Plasmodium berghei infection. During pregnancy 60% of the pre-exposed primiparous females showed pregnancy-induced malaria recrudescence and we demonstrated that the recrudescent P. berghei show an unexpected enhancement of the adherence to placenta tissue sections with a marked specificity for CSA. Furthermore, we showed that the intensity of parasitemia in primigravida was quantitatively correlated with the degree of thickening of the placental tissue and up-regulation of inflammation-related genes such as IL10. We also confirmed that the incidence of pregnancy-induced recrudescence, the intensity of the parasitemia peak and the impact on the pregnancy outcome decreased gradually from the first to the third pregnancy. Interestingly, placenta pathology and fetal impairment were also observed at low frequency among non-recrudescent females. Together, the data raise the hypothesis that recrudescent P. berghei displays selected specificity for the placenta tissue enabling on one hand, the triggering of the pathological process underlying PAM and on the other hand, the induction of PAM protection mechanisms that are revealed in subsequent pregnancies. Thus, by exploiting P. berghei pregnancy-induced recrudescence, this experimental system offers a mouse model to study the susceptibility to PAM and the mechanisms of disease protection in multigravida.
Claudio R F Marinho; Rita Neres; Sabrina Epiphanio; Lígia A Gonçalves; Manuela Beirão Catarino; Carlos Penha-Gonçalves
Related Documents :
3401135 - Retinal sensitivity over drusen and nondrusen areas. a study using fundus perimetry.
24592095 - Effect of the afterloaded external guidance embryo transfer technique on pregnancy rate...
22447695 - Dynamic proteome in enigmatic preeclampsia: an account of molecular mechanisms and biom...
23496415 - Age at menarche and pregnancy-related pelvic pain.
7174545 - Lamb growth patterns following different seasons of birth.
16997455 - Sperm retrieval rates in subgroups of primary azoospermic males.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-05-20
Journal Detail:
Title:  PloS one     Volume:  4     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2009  
Date Detail:
Created Date:  2009-05-22     Completed Date:  2009-07-20     Revised Date:  2013-06-02    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e5630     Citation Subset:  IM    
Instituto Gulbenkian de Ciência, Oeiras, Portugal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / metabolism
Cell Adhesion
Disease Susceptibility
Erythrocytes / cytology,  parasitology
Gene Expression Regulation
Gravidity / immunology*
Green Fluorescent Proteins / metabolism
Malaria / parasitology
Mice, Inbred BALB C
Parasitemia / parasitology
Placenta / blood supply,  parasitology*,  pathology
Plasmodium berghei / cytology,  metabolism*
Reg. No./Substance:
0/Biological Markers; 147336-22-9/Green Fluorescent Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
ISSN: 1932-6203
Publisher: Public Library of Science, San Francisco, USA
Article Information
Download PDF
Marinho et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received Day: 25 Month: 2 Year: 2009
Accepted Day: 27 Month: 4 Year: 2009
collection publication date: Year: 2009
Electronic publication date: Day: 20 Month: 5 Year: 2009
Volume: 4 Issue: 5
E-location ID: e5630
ID: 2680968
PubMed Id: 19461965
Publisher Id: 09-PONE-RA-08908R1
DOI: 10.1371/journal.pone.0005630

Recrudescent Plasmodium berghei from Pregnant Mice Displays Enhanced Binding to the Placenta and Induces Protection in Multigravida Alternate Title:Pregnancy-Recrudescent Malaria
Claudio R. F. Marinho14
Rita Neres1
Sabrina Epiphanio24
L?gia A. Gon?alves1
Manuela Beir?o Catarino3
Carlos Penha-Gon?alves1*
Georges Snounouedit1 Role: Editor
1Instituto Gulbenkian de Ci?ncia, Oeiras, Portugal
2Unidade de Mal?ria, Instituto de Medicina Molecular, Universidade de Lisboa, Lisboa, Portugal
3Faculdade de farm?cia, Universidade de Lisboa, Lisboa, Portugal
4Departamento de Ci?ncias Biol?gicas, Universidade Federal de S?o Paulo, Diadema, Brazil
Universit? Pierre et Marie Curie, France
Correspondence: * E-mail:
Contributed by footnote: Conceived and designed the experiments: CRFM RN CPG. Performed the experiments: RN SE LAG. Analyzed the data: CRFM RN SE LAG CPG. Contributed reagents/materials/analysis tools: MBC. Wrote the paper: CRFM RN MBC CPG.


It is estimated that more than 50 million pregnancies occur in malaria endemic areas per year, and approximately half of these occur in sub-Saharan Africa, where Plasmodium falciparum transmission is most intense [1]. In these regions adults tend to become protected from severe forms of the disease and from high-density parasitemia. Such protection appears to be partially lost during pregnancy when P. falciparum infection frequently courses with maternal and fetal morbidity leading to over 100.000 infant deaths in Africa every year [2]. Besides experiencing the common malaria symptoms, pregnant women suffer higher abortion rates and their offspring manifest intrauterine growth retardation in combination with low birth weight, which is a known risk factor for neonatal mortality [3], [4].

In pregnancy-associated malaria (PAM) the occurrence of stillbirths, premature and low-birth weight deliveries is attributable in part to maternal malaria-induced anemia [5], but the risk of low birth weight approximately doubles if women have placental malaria [6]. The infection of the placenta is characterized by accumulation of infected red blood cells (iRBC) in the intervillous spaces that, together with the concurrent placental pathology, could lead to fetal development impairment [7]. It has been proposed that the combined effect of parasite sequestration, massive intervillous inflammatory infiltration, thickening of the trophoblastic basement membrane and cytotrophoblast proliferation may disturb the transport of oxygen and nutrients across the placenta, impairing the development of the fetus [7].

It is widely accepted that a key component of the severe forms of P. falciparum malaria is the ability of the iRBC to adhere and be sequestered in various tissues. This is due to the interaction between parasite proteins expressed on the iRBC membrane and a variety of host receptors. In PAM, candidate host receptors for placental iRBC sequestration include a glycosaminoglycan, the low-sulphated chondroitin sulphate A (CSA) [8], which is spread throughout the intervillous spaces [9], [10]. Furthermore, it was shown that the gene var2csa is highly expressed in placental parasites [11] and confers enhanced CSA adhesion and specific antigenic properties to the iRBC [12]. These distinct antigens expressed by placental P. falciparum are considered major targets for acquired protective immunity to PAM [13], [14].

Epidemiological data strongly support the hypothesis that acquired immunity to placental P. falciparum is an effective protection mechanism in PAM [15]. Thus, in areas of high malaria transmission, it has been repeatedly observed that the risk of PAM decreases in multigravida. The severe clinical manifestations are mainly restricted to the first and second pregnancies [16], when the levels of specific antibodies against placental parasite antigens are not high enough to confer protection [17], [18]. Interestingly, in areas of infrequent malaria exposure, where women have little or no malaria immunity, the disease results in severe outcomes both for the mother and the baby, irrespective of parity [9], reinforcing the notion that the severity of clinical manifestations during pregnancy depends on pre-existing immunity of the mother [19]. Thus, malaria exposure through consecutive pregnancies is required for placental malaria immunity to develop and be maintained [15].

Nevertheless, in high transmission areas women that are exposed to malaria before pregnancy may show increased susceptibility to malaria during pregnancy but the parasite and host mechanisms that lead to parasite recrudescence are difficult to address in human populations. In addition, malaria can be asymptomatic during pregnancy and have serious consequences for the developing fetus [9], [20] suggesting that complex pathogenesis mechanisms are linking parasite recrudescence, placenta pathology and pregnancy outcome. Moreover, the biological basis of the protection acquired by multigravida needs to be investigated in experimental systems that warrant absence of re-infection.

In the 1980 s, van Zon and Eling provided seminal descriptions of pregnancy-induced malaria recrudescence in mice [20], [21] and noted higher vulnerability to malaria in pregnant female mice. Recently, we have shown that the main pathological features of severe PAM are reproduced in a mouse model [22] and Megnekou et al. [23] evidenced that pregnant mice accumulated specific antibodies against recrudescent parasite. These reports point to the value of mouse models as a research tool in pregnancy malaria. Here we extended our studies on experimental PAM and investigated whether pregnancy-induced P. berghei ANKA recrudescence correlated with placenta pathology, decreased with parity and was associated with enhanced binding of the recrudescent parasite to placental tissue.

Materials and Methods
Animals, parasites and infection

BALB/c mice were bred and maintained in conventional housing and fed with regular diet. All procedures were in accordance with national regulations on animal experimentation and welfare, authorized by the Instituto Gulbenkian de Ci?ncia animal welfare committee. Infection experiments were performed in adult females, between 10?15 weeks of age. P. berghei ANKA constitutively expressing green fluorescent protein (P. berghei ANKA-GFP) (259Cl2 clone) [24], [25]. The mice were infected intra-peritoneally (IP) with 106 iRBC obtained from frozen stocks and treated IP with 0.7 mg chloroquine for 3 days, starting at day 7 post-infection [26] and parasitemia was recorded every other day using flow cytometry analysis as described elsewhere [27]. Five to ten percent of the female mice exposed to this treatment succumbed but the remaining recovered from the infection after chloroquine therapy and were used in pregnancy-induced recrudescence experiments.

Parasite recrudescence and offspring monitoring

Forty days post-infection a group of treated females were put to mate and the remaining were used as non-pregnant controls. Detection of the vaginal plug and measurement of body weight were jointly used to time gestation, as previously described [28]. The day of vaginal plug detection was considered as gestational day one (G1). Pregnancy was confirmed between G10 and G13 when the animals had an average increase of 3?4 g in body weight. Thus, weight gain was taken as sign of pregnancy and sudden weight loss as an indicator of pregnancy injury or interruption. Some of the pregnant females were subjected to caesarian section at G19 for placenta pathology studies, while the others were allowed to deliver and to follow to subsequent pregnancies. At delivery, the weight and the number of live newborns were registered. Newborns weight and development was followed up to day 30 after birth. Non-infected pregnant females were used as controls.

Placentas collection and histopathological analysis

Females were killed by CO2 narcosis at G19. Placentas from infected and non-infected pregnant females were treated in a similar way. Placentas were separated in two halves, one half was frozen for RNA extraction and the other was fixed in 10% formalin for further processing. Paraffin-embedded non-consecutive placenta sections were stained with hematoxylin-eosin (HE) and examined in light microscopy (Leica DM LB2, Leica Microsystems). For histological and morphometric analysis, placental sections were blindly examined as previously described [22].

Gene-Specific Expression by qRT-PCR

Total RNA, from individual placentas and viable newborns, was obtained using an RNeasy Mini Kit (Qiagen), following the manufacturer's protocol for animal tissues. One microgram of total RNA was converted to cDNA (Transcriptor First Strand cDNA Synthesis Kit, Roche) using random hexamer primers. MCP-1 (Ccl2) and MIP-1? (Ccl3) expression was quantified using TaqMan Gene Expression Assays from ABI (Mm00441242_m1 and Mm00441258_m1, respectively) with TaqMan Universal PCR master mix. T lymphocytes (Cd3e), natural killer cells (Klrd1), macrophages (Mgl2), neutrophils (Ncf2), cytokines and hemoxygenase-1 (Hmox-1) expression was amplified using primer sequences previously described [29]. Endothelin-1 (Edn1) and ?-actin (Actb) specific primer sequences were, Edn1-[gene: 5?-ACG CAC AAC CGA GCA CAT TGA CTA C-3?]and [gene: 5? TCC TGC CCG TCT GAA CAA GAA ACT G-3?] and Actb-[gene: 5? AGC CAT GTA CGT AGC CAT CC-3?] and [gene: 5?-CTC TCA GCT GTG GTG GTG AA-3?]. These qRT-PCR reactions used Applied Biosystems Power SYBR Green PCR Master Mix. The gene expression quantification reactions were performed according to the manufacturers' instructions on an ABI Prism 7900HT system. Relative quantification of specific mRNA was normalized for a mouse housekeeping gene mRNA. To select an appropriate internal control, we studied the expression of the following housekeeping genes: ACTB, GAPDH, TATA box binding protein (TBP), Succcinate dehydrogenase complex, subunit A (SDHA) and Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (YWHAZ). The last three genes have been previously validated in human placental malaria [30]. Due to uneven gene expression, when comparing non-infected and infected placentas, the housekeeping genes TBP, SDHA and YWHAZ were unsuitable for internal controls. Conversely, ACTB and GAPDH expression was maintained under infection conditions.

Synchronization of parasitized erythrocytes

Infected red blood cells were obtained from infected non-pregnant mice, and from pregnant females with recrudescence, having 10?20% parasitemia. In order to obtain mature blood stage parasite forms (trophozoites/ schizonts), P. berghei ANKA-GFP infected erythrocytes were synchronized as described elsewhere [31]. Usually, the mature forms enrichment yields over 90% of infected cells. The enriched infected erythrocytes preparations were suspended in PBS at a concentration of 108 iRBC/ml.

iRBC binding assays in placental sections

Placentas from uninfected BALB/c females, obtained at G19, were treated using a previously described protocol [10]. Briefly, the placentas were fixed in 2% formalin and 0.5% glutaraldehyde for 10 minutes, heated in a microwave oven before being paraffin-embedded, cut into sections of 5 ?m onto glass slides and then deparafinized and rehydrated. This fixation protocol aims to preserve the binding capacity of glycosaminoglycans in the placenta intervillous spaces. For placenta-receptor cleavage experiments, placental sections were incubated with 0.5 U/ml chondroitinase ABC (from Proteus vulgaris, Sigma) or heparinase II (from Flavobacterium heparinum, Sigma) as a negative control, or with PBS, for 2 periods of 2 hours at 37?C. Fifty microliters of synchronized iRBC suspension were overlaid onto each tissue section for 60 minutes at 37?C in a humid chamber. For iRBC-ligand blocking experiments, synchronized iRBC were preincubated, for 30 minutes at 37?C, with CSA from bovine trachea (Sigma) or colominic acid sodium salt (CA) from E. coli (Sigma) as negative control, using the concentration of 1 mg/ml for each. This concentration was chosen to achieve maximum binding inhibition, while lower concentrations such as 100 mg/ml led to about 50% inhibition of specific binding (data not shown). The slides were mounted with Mowiol and examined under fluorescence microscopy at 40? magnification. The number of fluorescent green fluorescent iRBC adhering placenta sections in each experimental condition was determined in a blind fashion and counting for each section 50 microscopic fields.

Statistical analysis

Statistical differences between groups of mice were evaluated by the Student-t or Mann-Whitney tests. Chi-square or Pearson tests were used for association or correlation analysis, respectively.

Pregnancy-induced malaria recrudescence and poor pregnancy outcome

A total of one hundred female mice were infected with P. berghei-parasitized red blood cells and subsequently treated with chloroquine, typically showing a transient parasitemia peak, which eventually resolved. In absence of pregnancy, parasitemia remained essentially subpatent and was not observed thereafter (Figure 1A). In contrast, parasite recrudescence was frequently observed when malaria-treated females become pregnant (Figure 1A), more often after gestation day 14 (G14) but never before G12. We followed the first pregnancy of eighty-four pre-exposed females and found out that forty nine (58%) showed parasite recrudescence induced by pregnancy. Twenty-nine recrudescent females were followed to the end of pregnancy and we observed uncontrolled parasitemia leading to severe malaria and eventually to maternal death in nine of those females (31%) while the remaining controlled the parasitemia peak and were apparently cured. These results confirm the hypothesis that subpatent P. berghei infection is exacerbated by pregnancy.

To evaluate the effect of pregnancy-induced malaria recrudescence in the pregnancy outcome we monitored the offspring of primiparous recrudescent females (Figure 1B). The twenty-nine recrudescent mothers had significantly smaller litter sizes (average of 1.9 newborns/litter) as compared to twenty non-infected females (5.9 newborns/litter in average). Likewise, the average birth weight of newborns from recrudescent mothers (1.1 g) was significantly lower when compared to the newborns from non-infected mothers (1.4 g). These findings indicate that recrudescent females show poor pregnancy outcome that is characterized by decreased fetal viability and intra-uterine growth retardation.

Parasitemia recrudescence correlates with placenta pathology

The poor pregnancy outcome in females infected during pregnancy is associated with a placental inflammatory response that leads to marked tissue disorganization [22], and the presence of maternal iRBC of different stages of maturation in the placenta. In recrudescent primiparous females the intensity of peripheral parasitemia was quantitatively correlated with the reduction of the placental vascular spaces (P-value?=?0.0012) (Figure 2A). In particular, recrudescent females with high parasitemia showed increased reduction of vascular spaces. These results strongly suggest that malaria recrudescence correlated with placental tissue damage (Figure 2C and D) that possibly underlies the observed poor pregnancy outcomes. Furthermore, the expression analysis of cell-type specific genes in placentas from females with recrudescence, revealed increased amounts of inflammatory cells, particularly natural killer (NK) cells, T cells and macrophages (Figure 3A) and up-regulation of macrophages attractant chemokines (MCP-1 and MIP1-?) (Figure 3B).

We also found that the expression of several molecules related to vascular stress, namely hemoxygenase-1 (HO-1) and endothelin-1 (ET-1), was increased in placentas of recrudescent females (Figure 3D). TNF-? expression showed a trend to increase in infected placentas and the balance of the immuno-modulatory molecules IL-12 and IL-10 expression denoted an anti-inflammatory response in the course of the placenta malaria pathogenesis (Figure 3C). In fact, IL-10 expression was particularly increased in placentas where pathology was more intense (Figure 3E).

Enhanced adhesion of recrudescent P. berghei - GFP

iRBC sequestration appears to be the pathogenic trigger of the placenta pathology observed in pregnant women and we have previously shown that P. berghei iRBC specifically adhere to the mouse placenta tissue. To evaluate the adhesion properties of the recrudescent P. berghei we performed adhesion assays on placental sections that compared the adhesion properties of iRBC collected from recrudescent primiparous females with iRBC isolated from infected males and non-pregnant females. Strikingly, the amount of iRBC adhering to the placenta sections was four-fold increased in the samples from recrudescent primiparous females (Figure 4A). The adhesion of the recrudescent parasite was partially inhibited when the placental sections were treated with chondroitinase (70%), and also when the iRBC were pre-incubated with CSA (56%) (Figure 4B). These results indicate that CSA is involved in the adhesion of the recrudescent parasite to the placenta tissue and suggest that the recrudescent P. berghei expanding during pregnancy displays enhanced specificity to the placenta and consequently may induce a specific host response to the pregnancy-associated parasite.

Pregnancy-induced recrudescence and disease severity are reduced in multiparity

To test whether pregnant females were able to mount a response upon exposure to the recrudescent parasite, we followed up the fate of thirty-two primigravida in subsequent pregnancies. The pregnancy-induced peripheral parasitemia peak was graded as high recrudescence, if higher than 5%, and as patency, if between 1% and 5%, while the pregnant females with less than 1% of iRBC as detected by FACS analysis were declared non-recrudescent. We found that the aggregate incidence of high recrudescence and patency significantly decays from the first (59%) to the second (41%) and third pregnancy (22%) (Figure 5A). The reduced incidence of cases with high pregnancy parasitemia peaks (more than 5% of iRBC) was particularly striking and close to a four-fold reduction from the first (44%) to the second pregnancy (12%). Accordingly, the level of parasitemia also decreased significantly when comparing first (14.5%?19.2%), second (3.9%?9.4%) and third pregnancy (2.0%?4.1%) (Figure 5B). Also, the litter size and the newborn birth weight were lower in the first pregnancy but recovered and approximated normal levels in subsequent pregnancies (Figure 6). Furthermore, analysis focused on recrudescent females revealed that maternal mortality associated to recrudescence decreases with parity (Table 1) suggesting a decrease in disease severity. These results suggest that females that are repeatedly exposed to recrudescent parasites during pregnancy develop a protective response that tends to control parasite recrudescence and placental malaria during subsequent pregnancies.

PAM protection in multigravida is not attributable to the age of the pregnant females as we observed that pregnancy-induced recrudescence incidence in primigravida was not reduced at older ages. In particular, females infected under 20 weeks of age presented about 55% of recrudescence and in the group of older females, with more than 20 weeks, the recrudescence was about 65%. Furthermore, pregnancy-induced recrudescence seems to be uncorrelated with the period between infection and the first pregnancy, since we were able to observe recrudescence 40 weeks after infection. These data suggest that both the age of the mother and the duration of subpatent parasitemia are not determining factors in triggering parasite recrudescence.

It is worth noting that, regardless the number of previous pregnancies, the placentas from recrudescent females typically showed iRBC in the maternal blood spaces, inflammatory infiltrates, erythroblast accumulation in the fetal blood, placenta architecture disruption and trophoblast basal membrane thickening (data not shown). We noted that among non-recrudescent females the litter size was below normal levels and that irrespective of parity, about ten percent died during pregnancy or shortly after delivery (Table 2). The analysis of non-recrudescent placentas in some cases revealed the presence of iRBC and tissue lesions resembling the pathology observed in recrudescent females (Figure 7). These data suggest that albeit at low frequency, placental malaria occurs in absence of peripheral parasitemia recrudescence. Together, this study suggest that pregnancy-associated malaria evoked by recrudescent P. berghei is attributable to parasites with enhanced specificity for the placental tissue that are able to induce an inflammatory response during pregnancy and a cumulative protective response in multigravida that had experienced recrudescences induced by pregnancy


In this paper we analyzed a mouse model of pregnancy-induced malaria recrudescence in which the intensity of parasite recrudescence showed to be quantitatively correlated with the placenta pathology and the recrudescence incidence decreased with parity. Furthermore, we showed that the recrudescent parasite displays enhanced adhesion to the placenta suggesting that P. berghei could be helpful in investigating and clarifying the intricate mechanisms governing the increased risk of malaria recrudescence induced by pregnancy [34], [35].

Our experiments in mice clearly support the possibility that PAM in pre-exposed individuals does not require re-infection and suggest that malaria recrudescence during pregnancy can be caused by pregnancy-specific mechanisms that remain to be identified. These results are well in line with early findings by van Zon and Eling [20], [32] and more recently by Megnekou et al. [23] reporting P. berghei peripheral recrudescence in pregnant female mice that acquired the infection before conception. Moreover, in our analysis parasite recrudescence was never detected before gestation day 12 (G12), and most frequently parasitemia arose after G14. Placental development studies show that at G10.5 maternal blood starts to be evident in the labyrinth but only by G12.5 the definitive placenta becomes functional [38]. These observations converge to the notion that the placenta plays a critical role in development of murine PAM, possibly by promoting parasite recrudescence.

One of the currently proposed roles for the placenta in PAM pathogenesis is to provide new ligands that are recognized by the iRBC. We have previously shown that P. berghei binds CSA and hyaluronic acid [22] and in this study we demonstrated that iRBC collected from recrudescent females displayed a marked enhancement of CSA binding properties. The role of hyaluronic acid in the iRBC-placenta interaction has been to a certain extent controversial [33]?[35], but we observed that hyaluronidase and pre-incubation with hyaluronic acid inhibit the binding of recrudescence iRBCs to the placenta (data not shown). The adhesion assays clearly indicate that recrudescent P. berghei iRBC have higher ability to adhere to the placenta, raising the hypothesis that P. berghei expanding during PAM is positively selected by the ability to bind placental ligands. This hypothesis is supported by very recent work showing that pregnant mice acquire immunity specific to the recrudescent parasite [23]. This would parallel previous reasoning suggesting that in human PAM specific P. falciparum variants, such as the variant expressing the PfEMP1 molecule encoded by the var gene var2csa, are expanded via the increased cytoadherence of the iRBC to the placental receptors, prominently the CSA [39]. It is noteworthy that P. berghei variant antigens were not described so far, even though antigenic variation had been shown in other murine malaria species, such as P. chabaudi AS [36], [37]. Nevertheless, our data opens the possibility that murine PAM entails an overrepresentation of P. berghei - iRBC displaying parasite components that mediate the iRBC-placenta interactions. Thus, this model provides an opportunity to study the molecular mechanisms that promote the expansion of placenta-binding parasites also observed in human PAM.

In the course of P. falciparum infections, the placenta can harbor a striking density of parasites, macrophages, haemozoin and excess of fibrinoid deposits associated to morphologic alterations, such as syncytiotrophoblast necrosis and trophoblast basement membrane thickening [38] that would be harmful to the developing fetus, as the placental exchanges of respiratory gases and nutrients became difficult and reduced. We previously demonstrated that these characteristics can also be observed in the model system using BALB/c mice and P. berghei ANKA [22]. A remarkable pathological finding in P. berghei ANKA recrudescent placentas was the reduction of blood sinusoids space that is attributable to placental tissue thickening (Figure 2D). In addition, we showed that the reduction of the blood sinusoidal space is highly dependent on the parasitemia level (Figure 2A), reinforcing the notion that the parasite has a pivotal role in the genesis of the placental pathology.

Cytoadherence of P. berghei?infected erythrocytes to receptors expressed on the syncytiotrophoblast surface is considered to contribute to the described placental disorders, but it is not a sufficient condition for pathogenesis [39]. Placental malaria studies propose that the observed intervillositis is mostly an immunopathologic process, due to cytokines and chemokines production and leading to the activation of the syncytiotrophoblast [40], [41].

Monocytic/macrophagic infiltrate has been considered a hallmark of Plasmodium-infected placentas [39], [42], [43]. We had previously verified that infected P. berghei-GFP mouse placentas had an accumulation of mononuclear cells [22]. It is important to remark that in mouse placentas we observed low degree of massive chronic intervillositis as compared to reported observations in infected human placentas [44]. Possibly this difference is related to the short pregnancy time span that may condition the inflammatory process in the mouse as compared to human pregnancy. The expression profile of inflammatory genes suggests that, at the end of the pregnancy period, the placentas of recrudescent mice undergo a strong inflammatory process. This is inferred from the significant increase of cell-type specific markers for NK cells, T lymphocytes and macrophages as well as increased expression of chemoattractant factors (Figure 3A and B). Our results are in accordance with a recent study in Kenya showing NK and T cell infiltration in P. falciparum-infected human placentas [45]. It remains to be resolved whether T cell infiltration corresponds to activated effector T cells or to T regulatory cells as part of a placenta anti-inflammatory response. Interestingly, in our model, IL-12 expression in the placenta was significantly decreased (Figure 3C), while the expression of TNF alpha and IL-10 was increased. This down-regulation of IL-12 production, presumably from its main cell sources was suggested to be due to the inhibitory effects of hemozoin [46]. These observations allow the speculation that the strong local inflammatory environment generated by the iRBC adhesion is counteracted by a systemic anti-inflammatory response. In fact, we noted that the up-regulation of IL10 expression was correlated with the severity of placenta pathology (Figure 3E). Coincidently, IL-10 levels in the serum have been associated with poor pregnancy outcomes and was suggested as a biomarker for placenta inflammation in pregnant women [47]. Placenta microcirculation is in part controlled through a fine balance between different vasoconstrictors such as ET-1, and vasodilators, namely nitric oxide or HO-1 enzyme [48], [49]. Recrudescent placentas showed increased ET-1 and HO-1 mRNA expression, suggesting that the placenta vasculature is exposed to abnormal vasoactive regulation. Interestingly, we found that in some non-recrudescent females, the placentas could harbor a very low density of iRBC, which nevertheless seemed high enough to trigger placenta pathology (Figure 7). We speculate that these pathologic mechanisms would explain the death of pregnant females that do not show peripheral parasitemia but exhibit placental pathology.

There is solid epidemiological evidence from high-endemicity malaria regions that the incidence of PAM in women is parity-dependent [1]. In mice, reduced recrudescence has been observed in multigravida after anti-malaria treatments during the first pregnancy [36]. In the PAM mouse model described here we have also found that the disease incidence and severity decreased with parity. Nevertheless, we did not find a correlation between the intensity of the parasitemia peak in the pre-mating period and the occurrence of pregnancy-induced recrudescence in the first pregnancy, implying that such exposure did not confer PAM protection. These observations compelled us to hypothesize that PAM protection is acquired through repeated exposure to the recrudescent parasite on line with a recent report on accumulation of immunity to PAM over several pregnancies and recrudescences [24]. In this context, a possible extension of this model could be the repeated pre-exposure of females before pregnancy. This could help to evaluate the robustness of protection conferred by non-pregnant parasites.

Here, we report on the analysis of a mouse model of pregnancy-induced parasite recrudescence that displayed features resembling those of PAM in women living in high-endemicity regions. This work further supports the notion that this mouse model may become a helpful tool to dissect the molecular and cellular components involved in parasite recrudescence during pregnancy and to identify the details of the immunological mechanisms conferring PAM protection.


Competing Interests: The authors have declared that no competing interests exist.

Funding: This work, CRFM, RN and LAG were supported by the Funda??o para a Ci?ncia e Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

We acknowledge the technical assistance of Marisa Pardal in histological preparations and Joana Rodo and Jo?o Neres for critical reading of the manuscript.

1. WHO. 2004A strategic framework for malaria prevention and control during pregnancy in the African region. Geneva: World Health Organization AFR/MAL;
2. Guyatt HL,Snow RW. 2004;Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa.Clin Microbiol Rev 17:760–769, table of contents. [pmid: 15489346]
3. Steketee RW,Wirima JJ,Hightower AW,Slutsker L,Heymann DL,et al. 1996;The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi.Am J Trop Med Hyg 55:33–41. [pmid: 8702035]
4. Shulman CE,Marshall T,Dorman EK,Bulmer JN,Cutts F,et al. 2001;Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae.Trop Med Int Health 6:770–778. [pmid: 11679125]
5. Menendez C,Ordi J,Ismail MR,Ventura PJ,Aponte JJ,et al. 2000;The impact of placental malaria on gestational age and birth weight.J Infect Dis 181:1740–1745. Epub 2000 May 1715 [pmid: 10823776]
6. van Geertruyden JP,Thomas F,Erhart A,D'Alessandro U. 2004;The contribution of malaria in pregnancy to perinatal mortality.Am J Trop Med Hyg 71:35–40. [pmid: 15331817]
7. Brabin BJ,Romagosa C,Abdelgalil S,Menendez C,Verhoeff FH,et al. 2004;The sick placenta-the role of malaria.Placenta 25:359–378. [pmid: 15081631]
8. Fried M,Duffy PE. 1996;Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.Science 272:1502–1504. [pmid: 8633247]
9. Nosten F,Rogerson SJ,Beeson JG,McGready R,Mutabingwa TK,et al. 2004;Malaria in pregnancy and the endemicity spectrum: what can we learn?Trends Parasitol 20:425–432. [pmid: 15324733]
10. Muthusamy A,Achur RN,Bhavanandan VP,Fouda GG,Taylor DW,et al. 2004;Plasmodium falciparum-infected erythrocytes adhere both in the intervillous space and on the villous surface of human placenta by binding to the low-sulfated chondroitin sulfate proteoglycan receptor.Am J Pathol 164:2013–2025. [pmid: 15161637]
11. Salanti A,Staalsoe T,Lavstsen T,Jensen AT,Sowa MP,et al. 2003;Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria.Mol Microbiol 49:179–191. [pmid: 12823820]
12. Fried M,Domingo GJ,Gowda CD,Mutabingwa TK,Duffy PE. 2006;Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta.Exp Parasitol 113:36–42. Epub 2006 Jan 2023 [pmid: 16430888]
13. Hviid L,Salanti A. 2007;VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria.Parasitology 134:1871–1876. [pmid: 17958922]
14. Salanti A,Dahlback M,Turner L,Nielsen MA,Barfod L,et al. 2004;Evidence for the involvement of VAR2CSA in pregnancy-associated malaria.J Exp Med 200:1197–1203. [pmid: 15520249]
15. Hviid L. 2004;The immuno-epidemiology of pregnancy-associated Plasmodium falciparum malaria: a variant surface antigen-specific perspective.Parasite Immunol 26:477–486. [pmid: 15771683]
16. Menendez C. 2006;Malaria during pregnancy.Curr Mol Med 6:269–273. [pmid: 16515517]
17. Staalsoe T,Megnekou R,Fievet N,Ricke CH,Zornig HD,et al. 2001;Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia.J Infect Dis 184:618–626. Epub 2001 Aug 2009 [pmid: 11494167]
18. O'Neil-Dunne I,Achur RN,Agbor-Enoh ST,Valiyaveettil M,Naik RS,et al. 2001;Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy.Infect Immun 69:7487–7492. [pmid: 11705924]
19. Menendez C. 1995;Malaria during pregnancy: a priority area of malaria research and control.Parasitol Today 11:178–183. [pmid: 15275350]
20. van Zon AA,Eling WM. 1980;Depressed malarial immunity in pregnant mice.Infect Immun 28:630–632. [pmid: 6995314]
21. van Zon AA,Eling WM,Hermsen CC. 1985;Pregnancy-induced recrudescences strengthen malarial immunity in mice infected with Plasmodium berghei.Parasitology 91:9–17. [pmid: 3897957]
22. Neres R,Marinho CR,Goncalves LA,Catarino MB,Penha-Goncalves C. 2008;Pregnancy outcome and placenta pathology in Plasmodium berghei ANKA infected mice reproduce the pathogenesis of severe malaria in pregnant women.PLoS ONE 3:e1608. [pmid: 18270595]
23. Megnekou R,Hviid L,Staalsoe T. 2009;Variant-specific immunity to Plasmodium berghei in pregnant mice.Infect Immun 23:23.
24. Janse CJ,Franke-Fayard B,Mair GR,Ramesar J,Thiel C,et al. 2006;High efficiency transfection of Plasmodium berghei facilitates novel selection procedures.Mol Biochem Parasitol 145:60–70. Epub 2005 Oct 2007 [pmid: 16242190]
25. Janse CJ,Franke-Fayard B,Waters AP. 2006;Selection by flow-sorting of genetically transformed, GFP-expressing blood stages of the rodent malaria parasite, Plasmodium berghei.Nat Protoc 1:614–623. [pmid: 17406288]
26. Poels LG,van Niekerk CC,Pennings L,Agterberg J,van Elven EH. 1977;Plasmodium berghei: formation of secondary immune complexes in hyperimmune mice.Exp Parasitol 43:255–267. [pmid: 330189]
27. Janse CJ,Van Vianen PH. 1994;Flow cytometry in malaria detection.Methods Cell Biol 42:295–318. [pmid: 7533245]
28. Freyre A,Falcon J,Mendez J,Rodriguez A,Correa L,et al. 2006;Refinement of the mouse model of congenital toxoplasmosis.Exp Parasitol 113:154–160. Epub 2006 Feb 2015 [pmid: 16469312]
29. Epiphanio S,Mikolajczak SA,Goncalves LA,Pamplona A,Portugal S,et al. 2008;Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection.Cell Host Microbe 3:331–338. [pmid: 18474360]
30. Boeuf P,Tan A,Romagosa C,Radford J,Mwapasa V,et al. 2008;Placental hypoxia during placental malaria.J Infect Dis 197:757–765. [pmid: 18279052]
31. Janse CJ,Ramesar J,Waters AP. 2006;High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei.Nat Protoc 1:346–356. [pmid: 17406255]
32. van Zon AA,Eling WM. 1980;Pregnancy associated recrudescence in murine malaria (Plasmodium berghei).Tropenmed Parasitol 31:402–408. [pmid: 7015633]
33. Beeson JG,Rogerson SJ,Cooke BM,Reeder JC,Chai W,et al. 2000;Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria.Nat Med 6:86–90. [pmid: 10613830]
34. Rasti N,Namusoke F,Chene A,Chen Q,Staalsoe T,et al. 2006;Nonimmune immunoglobulin binding and multiple adhesion characterize Plasmodium falciparum-infected erythrocytes of placental origin.Proc Natl Acad Sci U S A 103:13795–13800. Epub 12006 Aug 13731 [pmid: 16945914]
35. Muthusamy A,Achur RN,Valiyaveettil M,Botti JJ,Taylor DW,et al. 2007;Chondroitin sulfate proteoglycan but not hyaluronic acid is the receptor for the adherence of Plasmodium falciparum-infected erythrocytes in human placenta, and infected red blood cell adherence up-regulates the receptor expression.Am J Pathol 170:1989–2000. [pmid: 17525266]
36. Phillips RS,Brannan LR,Balmer P,Neuville P. 1997;Antigenic variation during malaria infection?the contribution from the murine parasite Plasmodium chabaudi.Parasite Immunol 19:427–434. [pmid: 9347519]
37. Janssen CS,Barrett MP,Turner CM,Phillips RS. 2002;A large gene family for putative variant antigens shared by human and rodent malaria parasites.Proc Biol Sci 269:431–436. [pmid: 11886633]
38. Walter PR,Garin Y,Blot P. 1982;Placental pathologic changes in malaria. A histologic and ultrastructural study.Am J Pathol 109:330–342. [pmid: 6758604]
39. Schofield L. 2007;Intravascular infiltrates and organ-specific inflammation in malaria pathogenesis.Immunol Cell Biol 85:130–137. [pmid: 17344907]
40. Fievet N,Moussa M,Tami G,Maubert B,Cot M,et al. 2001;Plasmodium falciparum induces a Th1/Th2 disequilibrium, favoring the Th1-type pathway, in the human placenta.J Infect Dis 183:1530–1534. Epub 2001 Apr 1513 [pmid: 11319691]
41. Lucchi NW,Peterson DS,Moore JM. 2008;Immunologic activation of human syncytiotrophoblast by Plasmodium falciparum.Malar J 7:42. [pmid: 18312657]
42. Rogerson SJ,Pollina E,Getachew A,Tadesse E,Lema VM,et al. 2003;Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes.Am J Trop Med Hyg 68:115–119. [pmid: 12556159]
43. Diouf I,Fievet N,Doucoure S,Ngom M,Gaye A,et al. 2004;Monocyte activation and T cell inhibition in Plasmodium falciparum-infected placenta.J Infect Dis 189:2235–2242. Epub 2004 May 2225 [pmid: 15181571]
44. Ordi J,Ismail MR,Ventura PJ,Kahigwa E,Hirt R,et al. 1998;Massive chronic intervillositis of the placenta associated with malaria infection.Am J Surg Pathol 22:1006–1011. [pmid: 9706981]
45. Othoro C,Moore JM,Wannemuehler KA,Moses S,Lal A,et al. 2008;Elevated gamma interferon-producing NK cells, CD45RO memory-like T cells, and CD4 T cells are associated with protection against malaria infection in pregnancy.Infect Immun 76:1678–1685. Epub 2008 Feb 1674 [pmid: 18250175]
46. Luty AJ,Perkins DJ,Lell B,Schmidt-Ott R,Lehman LG,et al. 2000;Low interleukin-12 activity in severe Plasmodium falciparum malaria.Infect Immun 68:3909–3915. [pmid: 10858202]
47. Kabyemela ER,Muehlenbachs A,Fried M,Kurtis JD,Mutabingwa TK,et al. 2008;Maternal peripheral blood level of IL-10 as a marker for inflammatory placental malaria.Malar J 7:26. [pmid: 18230163]
48. Bourgeois C,Robert B,Rebourcet R,Mondon F,Mignot TM,et al. 1997;Endothelin-1 and ETA receptor expression in vascular smooth muscle cells from human placenta: a new ETA receptor messenger ribonucleic acid is generated by alternative splicing of exon 3.J Clin Endocrinol Metab 82:3116–3123. [pmid: 9284755]
49. Ahmed A,Rahman M,Zhang X,Acevedo CH,Nijjar S,et al. 2000;Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation.Mol Med 6:391–409. [pmid: 10952020]


[Figure ID: pone-0005630-g001]
doi: 10.1371/journal.pone.0005630.g001.
Figure 1  Malaria susceptibility is increased during pregnancy with detrimental effects for the progeny.

Representative parasitemia curves of BALB/c females infected with P. berghei - GFP (day 0) and treated with chloroquine for 3 days starting at day 7 (Panel A). Parasitemias of females maintained without male (non-pregnants) are represented in the upper plot. The lower plot shows 5 typical parasitemia curves of recrudescent primigravida. In Panel B average litter size and birth weight of 20 litters from non-infected primiparous females are compared with the average litter size of 29 litters and the birth weight average of 6 litters, from recrudescent primiparous females. Error bars represent standard error (***, p<0.001).

[Figure ID: pone-0005630-g002]
doi: 10.1371/journal.pone.0005630.g002.
Figure 2  Peripheral parasitemia correlates with the reduction of placental blood sinusoids area.

(A) The blood sinusoidal area is plotted against the peripheral parasitemia peak observed in the pregnancy of primiparous females. The area of placental blood sinusoids, expressed as a fraction of the total placental area, was obtained using an automated morphometric procedure as described in Materials and Methods section. In recrudescent females, the degree of parasitemia was correlated with sinusoidal area reduction (correlation coefficient for recrudescent females is 0.45, P-value?=?0.0012). Representative photomicrograph of placental sections HE stained from non-infected (B) and recrudescent (C?D) mothers. Accumulation of inflammatory cells (C), trophoblast thickening (arrows) and presence of iRBC (D) in blood sinusoids (arrowheads) are evidenced in placenta tissue from recrudescent mothers. Scale bars represent 15 ?m in (B?D).

[Figure ID: pone-0005630-g003]
doi: 10.1371/journal.pone.0005630.g003.
Figure 3  Placenta pathology is associated with altered gene expression of inflammation markers.

qRT-PCR of placenta tissue was used to detect the expression of cell type?specific genes indicating infiltration of inflammatory cells: Klrd1 gene for Natural Killer cells, Cd3e gene for T cells, Ncf2 gene for neutrophils and Mgl2 for macrophages (A). Placental gene expression was quantified for relevant markers of monocyte/macrophage chemotaxy (B), inflammation mediators (C) and vascular stress (D). RNA expression was quantified in 15 placentas from recrudescent primiparous BALB/c females and in 8 uninfected placentas, collected on G19. In (E) placental IL10 mRNA expression was separately analyzed in 5 placentas showing moderate pathology (+) and 4 placentas showing severe (++) pathology. Relative quantification was obtained with normalization by ?-actin for (A), (C), (D) and (E) and by GAPDH for (B). Results are plotted as fold change over the respective non-infected controls and each bar represents the mean?s.e.m. (*, P-value<0.05).

[Figure ID: pone-0005630-g004]
doi: 10.1371/journal.pone.0005630.g004.
Figure 4  P. berghei iRBC from recrudescent females show enhanced adhesion to placenta.

iRBC from males, non-pregnant females and recrudescent primiparous females were incubated on uninfected placental sections and the adherent parasitized cells were counted as described in Materials and Methods section (A). Adhesion assays were also performed after pre-treatment of placental sections with chondroitinase ABC or heparinase (negative control) (B, upper plot). Adhesion inhibition assays were carried out by pre-incubating iRBC from recrudescent females with 1 mg/ml concentrations of CSA or CA (negative control) (B, lower plot). In panel B the proportion of bound iRBC is expressed as a percentage of the control (non-treated placentas or non-preincubated iRBC, in upper and lower plots, respectively). Error bars represent the mean?s.e.m. of three independent experiments. (***, P-value<0.001).

[Figure ID: pone-0005630-g005]
doi: 10.1371/journal.pone.0005630.g005.
Figure 5  Recrudescence incidence and peripheral parasitemia are decreased in multigravida.

(A) Frequency of females with high recrudescence (above 5% parasitemia), patency (parasitemia between 1% and 5%) and no recrudescence (parasitemia <1%) according to parity. Recrudescence incidence is significantly associated with parity (P-value?=?0.001, Chi-square test). (B) Box-plots illustrate the range of the peripheral parasitemia peak according to parity. The parasitemia peak in the first pregnancy was significantly different from the second (P-value?=?0.004) and third pregnancies (P-value?=?0.006). * and ? represent extremes and outliers, respectively.

[Figure ID: pone-0005630-g006]
doi: 10.1371/journal.pone.0005630.g006.
Figure 6  Reduced adverse pregnancy outcomes in multigravida.

Box-plots of the average litter size (A) and average newborn birth weight (B) according to parity (first, second and third pregnancy). Pregnancy outcome was significantly different in primigravida as compared to multigravida and non-infected pregnant females (***, P-value<0.001; **, P-value<0.01; *, P-value<0.05).

[Figure ID: pone-0005630-g007]
doi: 10.1371/journal.pone.0005630.g007.
Figure 7  Occasional placenta pathology in non-recrudescent pregnant females.

Photomicrographs of HE-stained placental sections of sporadic cases of placental pathology in non-recrudescent females. The figure shows presence of iRBC adhered to the syncytiotrophoblast layer (A, insert) and in blood sinusoids (arrowheads) as well as trophoblast thickening (arrow). Scale bar represents 15 ?m.

[TableWrap ID: pone-0005630-t001] doi: 10.1371/journal.pone.0005630.t001.
Table 1  Disease severity and pregnancy outcome in P. berghei recrudescent females according to parity.
Parity Pregnant females Average parasitemia peak (%) Maternal mortality (%) Litter sizea Newborns Birth weight (g)a
Primigravida 29 22.7 31 1.9?3.0 (29) 1.1?0.2 (6)
Second Pregnancy 9 10.7 20 5.6?2.1 (9) 1.3?0.2 (7)
Third Pregnancy 3 3.4 0 6.7?1.2 (3) 1.3?0.1 (3)
Non-Infected 20 ___ 0 5.9?2.2 (20) 1.4?0.2 (20)

aMean?stdev (number of litters analyzed).

[TableWrap ID: pone-0005630-t002] doi: 10.1371/journal.pone.0005630.t002.
Table 2  Disease severity and pregnancy outcome in non-recrudescent females according to parity.
Parity Pregnant females Maternal mortality (%) Litter sizea Newborns Birth weight (g)a
Primigravida 22 12 3.2?3.3 (22) 1.4?0.2 (2)
Second Pregnancy 10 11 3.8?2.4 (10) 1.4?0.3 (4)
Third Pregnancy 13 8 3.5?0.2 (13) 1.5?0.7 (6)
Non-Infected 20 0 5.9?2.2 (20) 1.4?0.2 (20)

aMean?stdev (number of litters analyzed).

Article Categories:
  • Research Article
Article Categories:
  • Infectious Diseases/Protozoal Infections
  • Pathology/Histopathology
  • Pathology/Immunology

Previous Document:  Light induced changes in protein expression and uniform regulation of transcription in the thylakoid...
Next Document:  The cAMP-dependent protein kinase inhibitor H-89 attenuates the bioluminescence signal produced by R...